Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

AIDS Trestment News
December 17, 1999

AIDS Treatment News Index, 1999

2003 | 2002 | 2001 | 2000 | 1998 | 1997 | 1996


A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z


TopicDate and Issue #Title of Article
Aaron Diamond AIDS Research Center04-Jun-99 #320Eradication or Immune Control: New Research, Issue of Focus
abacavir08-Jan-99 #310Ziagen(TM) (Abacavir) Approved: Caution Essential
Abbott05-Nov-99 #330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Grinberg
Abbott Laboratories01-Oct-99 #328ABT-378 Early Access Program Begins
ABT-37801-Oct-99 #328ABT-378 Early Access Program Begins
ABT-37801-Oct-99 #328ICAAC: New Drugs in Late Breaker Session
access to care17-Dec-99 #333San Francisco General Hospital Funding Crisis: Call for Information
access to care19-Nov-99 #331Update on Tenofovir (PMPA) compassionate Access Study
access to care01-Oct-99 #328ABT-378 Early Access Program Begins
access to care16-Apr-99 #317San Francisco General Outpatient Pharmacy Problems
access to care19-Feb-99 #313Medical Marijuana: Major AIDS Organizations Seek Legal Access
access to care19-Feb-99 #313San Francisco: New HMO Problems threaten Access to Care
access to care08-Jan-99 #310 1999: Treatments, Issues to Watch
access, international17-Dec-99 #333Medical Donations for Cuba
access, international19-Nov-99 #331Seattle Trade Meeting: What Can Be Done for Treatment Access? Interview with James Love
access, international05-Nov-99 #330Pharmaceutical Patents and Developing Countries
access, international03-Sep-99 #326Activists Block Gore's Office to Protest Terms of Africa Deal
access, international03-Sep-99 #326Brazil May Stop Drug Access; Problems Also Reported from Argentina
access, international03-Sep-99 #326Seattle Demonstration Preparations for Global Trade Meetings
access, international06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
access, international02-Jul-99 #322Africa, Access, and Patents: Moving Fast
access, international18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
access, international04-Jun-99 #320 Panama: Modern Antiretroviral Treatment Will Be Available
access, international21-May-99 #319Hundred Million Dollar Program for Public-Private AIDS Research and Outreach in Africa
access, international07-May-99 #318Africa and HIV/AIDS: Email Communication List
access, international16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
access, international19-Mar-99 #315Health Gap Coalition -- New Group for International Treatment Access
access, international05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
access, international22-Jan-99 #311A Visit to India: Drug Prices, Research, & Global Access
activism17-Dec-99 #333San Francisco General Hospital Funding Crisis: Call for Information
activism17-Dec-99 #333Medical Donations for Cuba
activism17-Dec-99 #333Northern California: One-Day Advocacy Conference, January 29
activism05-Nov-99 #330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Grinberg
activism05-Nov-99 #330Pharmaceutical Patents and Developing Countries
adefovir05-Nov-99 #330Adefovir: FDA Committee Votes Against Approval
adefovir15-Oct-99 #329FDA Advisory Meetings: Adefovir, Nov. 1; Resistance Testing Nov. 2-3
AEGIS04-Jun-99 #320 AEGIS Nominated to UNESCO "Memory of the World"
Africa02-Jul-99 #322Africa, Access, and Patents: Moving Fast
Africa21-May-99 #319Hundred Million Dollar Program for Public-Private AIDS Research and Outreach in Africa
Africa07-May-99 #318Africa and HIV/AIDS: Email Communication List
Africa19-Mar-99 #315Health Gap Coalition -- New Group for International Treatment Access
African American07-May-99 #318Model AIDS Program Housed in African-American Church
African Growth and Opportunity Act19-Mar-99 #315Health Gap Coalition -- New Group for International Treatment Access
AGAPE Program07-May-99 #318Model AIDS Program Housed in African-American Church
Agenerase(TM)07-May-99 #318Amprenavir, New Protease Inhibitor, Approved
Agouron Pharmaceuticals07-May-99 #318Model AIDS Program Housed in African-American Church
AIDS Action20-Aug-99 #325AIDS Jobs Available
AIDS Research Alliance03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
AIDS Treatment News 08-Jan-99 #310AIDS Treatment News Financial Disclosure Update
alitretinoin19-Feb-99 #313Kaposi's Sarcoma: New Topical Treatment Approved
American Foundation for AIDS Research01-Oct-99 #328New AmFAR Treatment Directory Now Available
AmFAR01-Oct-99 #328New AmFAR Treatment Directory Now Available
Amplicor HIV Ultrasensitive Method05-Mar-99 #314Viral Load 50-Copy Test Approved
amprenavir07-May-99 #318Amprenavir, New Protease Inhibitor, Approved
anti-inflammatory21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
Antioch Baptist Church07-May-99 #318Model AIDS Program Housed in African-American Church
Argentina03-Sep-99 #326Brazil May Stop Drug Access; Problems Also Reported from Argentina
auctions19-Nov-99 #331Internet Fundraising: Online Auctions ...
Balm In Gilead, Inc.07-May-99 #318Model AIDS Program Housed in African-American Church
beginning treatment20-Aug-99 #325San Francisco General Hospital: Studies for Patients Beginning Antiretroviral Treatment
Beier, David16-Apr-99 #317Clinton/Gore Top Staffs: Pharmaceutical Background
benefits01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
benefits02-Apr-99 #316Medicare Recipients -- New Income Limits Can Increase Cash, Medical Benefits
benefits19-Feb-99 #313Keep Your Medicare in Force As You Go Back to Work (What to Do and When to Do It)
Berlin patient12-Feb-99 #312Restoring HIV-Specific Immunity
biological approaches17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
Bombay18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
Boneberg, Paul06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
Brazil03-Sep-99 #326Brazil May Stop Drug Access; Problems Also Reported from Argentina
Bristol-Myers Squibb19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
Bristol-Myers Squibb05-Nov-99 #330ddI: FDA Approves Once-Daily Dosing
Bristol-Myers Squibb21-May-99 #319Hundred Million Dollar Program for Public-Private AIDS Research and Outreach in Africa
Bristol-Myers Squibb07-May-99 #318Model AIDS Program Housed in African-American Church
Brown & Toland07-May-99 #318Managed Care Problems: San Francisco Hearing Set for May 13
bundling02-Jul-99 #322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
buyers' clubs17-Dec-99 #333Buyers' Club List, December 1999
calcium05-Mar-99 #314Neuropathy: Nutritional Prevention/Treatment Suggested
calendar20-Aug-99 #325Upcoming Research and Treatment Conferences, Meetings
California02-Jul-99 #322Medical Marijuana: California Task Force Proposes Registration System...
California02-Jul-99 #322Organ Transplants: One Million Dollars for Research
cannabinoids21-May-99 #319Medical Marijuana: AIDS- Related Information in the New Federal Report
cannabis17-Sep-99 #327Vaporizers for Medical Marijuana
capitation22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
CD8 cells15-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
Cent Gardes conference05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
CHAMP17-Sep-99 #327Vaporizers for Medical Marijuana
chloroquine03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
CHORUS database19-Feb-99 #313Strategy Trials: The Answer?
Claritin18-Jun-99 #321Action Alert: Drug-Patent Bill Could Cost Patients $3 Billion+...
Cleveland07-May-99 #318Model AIDS Program Housed in African-American Church
clinical trials20-Aug-99 #325San Francisco General Hospital: Studies for Patients Beginning Antiretroviral Treatment
clinical trials18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
clinical trials04-Jun-99 #320 HE2000 Begins Clinical Trials: Interview with James Frincke, Ph.D.
clinical trials04-Jun-99 #320 Treatment Interruption Research: The Trial Most Needed Now
clinical trials21-May-99 #319REMUNE Trial Will Stop; New Trials Planned
clinical trials08-Jan-99 #310Ziagen(TM) (Abacavir) Approved: Caution Essential
clinical trials, design19-Nov-99 #331FDA Clarifies Rules, Allows Combining Antiretrovirals in Clinical Trials
clinical trials, design19-Feb-99 #313Strategy Trials: The Answer?
clinical trials, design08-Jan-99 #310Improving Drug Development: Exploratory Clinical Studies
Clinton, President William16-Apr-99 #317Clinton/Gore Top Staffs: Pharmaceutical Background
Coalition for Salvage Therapy05-Nov-99 #330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Grinberg
compounding pharmacies02-Jul-99 #322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
compounding pharmacies04-Jun-99 #320 Threat to Compounding of Topical Testosterone, Other Pharmaceuticals: FDA Proposes Limit on Interstate Shipment
compulsory licensing16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
compulsory licensing05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
computer security16-Jul-99 #323Charges Dropped in Sex Sting; Protecting Yourself Online
conferences05-Nov-99 #330Durban Conference: February Deadlines, New Track, and Community Program
conferences05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
conferences, meetings -- lists20-Aug-99 #325Upcoming Research and Treatment Conferences, Meetings
Consumer Project on Technology16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
Consumer Project on Technology05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
copyleft03-Dec-99 #332Copyright Restrictions Block Non-English AIDS Information
copyright03-Dec-99 #332Copyright Restrictions Block Non-English AIDS Information
CST (Coalition for Salvage Therapy)05-Nov-99 #330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Grinberg
Cuba17-Dec-99 #333Medical Donations for Cuba
d4T19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
Davies Medical Center07-May-99 #318Managed Care Problems: San Francisco Hearing Set for May 13
ddI03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
ddI19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
ddI05-Nov-99 #330ddI: FDA Approves Once-Daily Dosing
developing countries see: access, international
diarrhea06-Aug-99 #324Diarrhea: New Treatment Option from Shaman
diclofenac sodium18-Jun-99 #321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
dietary supplements06-Aug-99 #324FDA Hearing Highlights Opposition to Dietary Supplement Practices...
dietary supplements18-Jun-99 #321FDA Public Meeting on Dietary Supplement Regulation...
disability01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
disability21-May-99 #319Medicaid Early Treatment Bill Now in Congress
disclosure08-Jan-99 #310AIDS Treatment News Financial Disclosure Update
DSHEA06-Aug-99 #324FDA Hearing Highlights Opposition to Dietary Supplement Practices...
DSHEA18-Jun-99 #321FDA Public Meeting on Dietary Supplement Regulation...
Durban05-Nov-99 #330Durban Conference: February Deadlines, New Track, and Community Program
email lists03-Dec-99 #332Treatment and Related AIDS Email Lists
email lists07-May-99 #318Africa and HIV/AIDS: Email Communication List
email lists07-May-99 #318U.S. Vaccine Trial: New Email List
employment20-Aug-99 #325AIDS Jobs Available
emulgel18-Jun-99 #321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
FDA19-Nov-99 #331FDA Clarifies Rules, Allows Combining Antiretrovirals in Clinical Trials
FDA19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
FDA05-Nov-99 #330Adefovir: FDA Committee Votes Against Approval
FDA05-Nov-99 #330ddI: FDA Approves Once-Daily Dosing
FDA15-Oct-99 #329FDA Advisory Meetings: Adefovir, Nov. 1; Resistance Testing Nov. 2-3
FDA06-Aug-99 #324FDA Hearing Highlights Opposition to Dietary Supplement Practices...
FDA18-Jun-99 #321FDA Public Meeting on Dietary Supplement Regulation...
FDA04-Jun-99 #320 Threat to Compounding of Topical Testosterone, Other Pharmaceuticals: FDA Proposes Limit on Interstate Shipment
financial disclosure08-Jan-99 #310AIDS Treatment News Financial Disclosure Update
fish oil16-Apr-99 #317Fish Oil Reduced Heart Disease in Controlled Trial
foreign assistance06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
funding06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
funding08-Jan-99 #310AIDS Treatment News Financial Disclosure Update
fundraising19-Nov-99 #331Internet Fundraising: Online Auctions ...
GAAN06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
Gallo, Robert17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
Gallo, Robert19-Mar-99 #315New Antiviral Substances Found with HCG
Gates, William H07-May-99 #318Gates Foundation Donates $25 Million for AIDS Vaccines
Geigy Pharmaceuticals18-Jun-99 #321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
generic drugs18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
genotypic testing02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
Getty, Jeff02-Jul-99 #322Organ Transplants: One Million Dollars for Research
Gilead Sciences19-Nov-99 #331Update on Tenofovir (PMPA) compassionate Access Study
Gilead Sciences05-Nov-99 #330Adefovir: FDA Committee Votes Against Approval
Glaxo Wellcome07-May-99 #318Amprenavir, New Protease Inhibitor, Approved
Glaxo Wellcome19-Mar-99 #315Lipodystrophy: Glaxo Researchers Suggest Mechanisms, Publish Data
Glide-Goodlett HIV/AIDS Project07-May-99 #318Model AIDS Program Housed in African-American Church
Global AIDS Action Network06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
Gore, Vice President Al03-Sep-99 #326Activists Block Gore's Office to Protest Terms of Africa Deal
Gore, Vice President Al02-Jul-99 #322Africa, Access, and Patents: Moving Fast
Gore, Vice President Al16-Apr-99 #317Clinton/Gore Top Staffs: Pharmaceutical Background
Gore, Vice President Al16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
Green, Chris03-Dec-99 #332Copyright Restrictions Block Non-English AIDS Information
guidelines03-Sep-99 #326Opportunistic Infections: New Treatment Guidelines Published August 20
guidelines21-May-99 #319Updated HIV Treatment Guidelines Available
HCG19-Mar-99 #315New Antiviral Substances Found with HCG
HE200004-Jun-99 #320 HE2000 Begins Clinical Trials: Interview with James Frincke, Ph.D.
Health Gap Coalition18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
Health Gap Coalition19-Mar-99 #315Health Gap Coalition -- New Group for International Treatment Access
heart disease16-Apr-99 #317Fish Oil Reduced Heart Disease in Controlled Trial
hepatitis C02-Jul-99 #322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
HIV Treatment Data Project19-Feb-99 #313Strategy Trials: The Answer?
HIV-specific immunity19-Nov-99 #331Restoring HIV- Specific Immunity: Telephone Conference December 8
HIV-specific immunity12-Feb-99 #312HIV-Specific Immunity: Major Conference Sessions
HIV-specific immunity12-Feb-99 #312Restoring HIV- Specific Immunity
HIV-specific immunity08-Jan-99 #310 1999: Treatments, Issues to Watch
HMOs19-Feb-99 #313San Francisco: New HMO Problems threaten Access to Care
HMOs22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
Hollis Eden04-Jun-99 #320 HE2000 Begins Clinical Trials: Interview with James Frincke, Ph.D.
HOPE for Africa Act19-Mar-99 #315Health Gap Coalition -- New Group for International Treatment Access
human chorionic gonadotropin19-Mar-99 #315New Antiviral Substances Found with HCG
human rights06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
hydroxychloroquine03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
hydroxyurea03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
hydroxyurea19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
hydroxyurea07-May-99 #318Interrupting HAART; Hydroxyurea; Five+ Drug Therapy -- Report from the RIGHT
hypersensitivity reaction08-Jan-99 #310Ziagen(TM) (Abacavir) Approved: Caution Essential
IAVI07-May-99 #318Gates Foundation Donates $25 Million for AIDS Vaccines
ICAAC01-Oct-99 #328ICAAC Conference Reports on Web
ICAAC01-Oct-99 #328ICAAC: New Drugs in Late Breaker Session
IL-2, low dose15-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
Immune Response Corporation21-May-99 #319REMUNE Trial Will Stop; New Trials Planned
immune system20-Aug-99 #325Poppers: More Evidence of Suppressed Immunity
immune system16-Apr-99 #317T-Cell Activation Predictive of Poor Survival in Advanced Disease
immune-based therapies15-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
immune-based therapies02-Jul-99 #322Immune Reconstitution: New Review on Web
immune-based therapies04-Jun-99 #320 Eradication or Immune Control: New Research, Issue of Focus
immune-based therapies12-Feb-99 #312HIV-Specific Immunity: Major Conference Sessions
immune-based therapies12-Feb-99 #312Restoring HIV- Specific Immunity
India18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
India22-Jan-99 #311A Visit to India: Drug Prices, Research, & Global Access
Indonesia03-Dec-99 #332Copyright Restrictions Block Non-English AIDS Information
Institute of Human Virology17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
Institute of Medicine17-Sep-99 #327Vaporizers for Medical Marijuana
Institute of Medicine21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
intellectual property03-Dec-99 #332Copyright Restrictions Block Non-English AIDS Information
International AIDS Candlelight Memorial07-May-99 #318International AIDS Candlelight Memorial and Mobilization, May 16
International AIDS Vaccine Initiative07-May-99 #318Gates Foundation Donates $25 Million for AIDS Vaccines
Internet19-Nov-99 #331Internet Fundraising: Online Auctions ...
IPAs22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
Kaiser, Jon05-Mar-99 #314Neuropathy: Nutritional Prevention/Treatment Suggested
Kaposi's sarcoma19-Feb-99 #313Kaposi's Sarcoma: New Topical Treatment Approved
Kaufman, David18-Jun-99 #321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
Kuala Lumpur05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
Levin, Jules16-Jul-99 #323New York Area and Worldwide: Call-In Radio Program on HIV
Levin, Jules07-May-99 #318Interrupting HAART; Hydroxyurea; Five+ Drug Therapy -- Report from the RIGHT
lipodystrophy19-Mar-99 #315Lipodystrophy: Glaxo Researchers Suggest Mechanisms, Publish Data
Lisbon05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
listserves03-Dec-99 #332Treatment and Related AIDS Email Lists
listserves07-May-99 #318Africa and HIV/AIDS: Email Communication List
listserves07-May-99 #318U.S. Vaccine Trial: New Email List
Livesaving Vaccine Technology Act of 102-Apr-99 #316Vaccine and Microbicide Tax Credit Legislation Introduced in Congress
Los Angeles03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
Love, James16-Apr-99 #317Clinton/Gore Top Staffs: Pharmaceutical Background
Love, James05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
low-dose IL-215-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
MacDonald, Alex16-Apr-99 #317San Francisco General Outpatient Pharmacy Problems
magnesium05-Mar-99 #314Neuropathy: Nutritional Prevention/Treatment Suggested
mailing lists03-Dec-99 #332Treatment and Related AIDS Email Lists
Malaysia05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
managed care07-May-99 #318Managed Care Problems: San Francisco Hearing Set for May 13
managed care19-Feb-99 #313San Francisco: New HMO Problems threaten Access to Care
managed care22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
marijuana, medical17-Sep-99 #327Vaporizers for Medical Marijuana
marijuana, medical02-Jul-99 #322Medical Marijuana: California Task Force Proposes Registration System...
marijuana, medical21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
marijuana, medical19-Feb-99 #313Medical Marijuana: Major AIDS Organizations Seek Legal Access
maternal transmission16-Jul-99 #323Major Advance in Protecting Newborns: One Nevirapine Dose Cuts Infection in Half
McCormack, Thomas P01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
McCormack, Thomas P19-Feb-99 #313Keep Your Medicare in Force As You Go Back to Work (What to Do and When to Do It)
mechanisms17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
Medi-Cal01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
Medi-Cal21-May-99 #319Medicaid Early Treatment Bill Now in Congress
Medicaid01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
Medicaid21-May-99 #319Medicaid Early Treatment Bill Now in Congress
Medicare02-Apr-99 #316Medicare Recipients -- New Income Limits Can Increase Cash, Medical Benefits
Medicare19-Feb-99 #313Keep Your Medicare in Force As You Go Back to Work (What to Do and When to
meetings20-Aug-99 #325Upcoming Research and Treatment Conferences, Meetings
Merigan, Thomas02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
microbicides02-Apr-99 #316Vaccine and Microbicide Tax Credit Legislation Introduced in Congress
Mirken, Bruce17-Sep-99 #327Vaporizers for Medical Marijuana
mother-infant transmission16-Jul-99 #323Major Advance in Protecting Newborns: One Nevirapine Dose Cuts Infection in Half
Mumbai18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
National Minority AIDS Council20-Aug-99 #325AIDS Jobs Available
nausea21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
neuropathy18-Jun-99 #321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
neuropathy05-Mar-99 #314Neuropathy: Nutritional Prevention/Treatment Suggested
nevirapine16-Jul-99 #323Major Advance in Protecting Newborns: One Nevirapine Dose Cuts Infection in Half
news03-Dec-99 #332Copyright Restrictions Block Non- English AIDS Information
nitrite inhalants20-Aug-99 #325Poppers: More Evidence of Suppressed Immunity
nitrite inhalants16-Apr-99 #317Poppers: Large Cancer Increase and Immune Suppression in Animal Tests
NMAC20-Aug-99 #325AIDS Jobs Available
NORML17-Sep-99 #327Vaporizers for Medical Marijuana
Oakland Cannabis Buyers Club17-Sep-99 #327Vaporizers for Medical Marijuana
Office of National Drug Control Policy19-Feb-99 #313Medical Marijuana: Major AIDS Organizations Seek Legal Access
opportunistic infections03-Sep-99 #326Opportunistic Infections: New Treatment Guidelines Published August 20
organ transplantation02-Jul-99 #322Organ Transplants: One Million Dollars for Research
Owen, William19-Feb-99 #313San Francisco: New HMO Problems threaten Access to Care
Panama04-Jun-99 #320 Panama: Modern Antiretroviral Treatment Will Be Available
pancreatitis19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
Panretin(R)19-Feb-99 #313Kaposi's Sarcoma: New Topical Treatment Approved
Paris05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
patents05-Nov-99 #330Pharmaceutical Patents and Developing Countries
patents03-Sep-99 #326Activists Block Gore's Office to Protest Terms of Africa Deal
patents06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
patents02-Jul-99 #322Africa, Access, and Patents: Moving Fast
patents02-Jul-99 #322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
patents18-Jun-99 #321Action Alert: Drug-Patent Bill Could Cost Patients $3 Billion+...
patents18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
pathogenesis16-Apr-99 #317T-Cell Activation Predictive of Poor Survival in Advanced Disease
patient databases03-Sep-99 #326HIV & AIDS Treatment Registry Database: Public Registry Now Online
patient databases16-Jul-99 #323Web-Based Survey: Symptom Management for Persons Living with HIV
Pelosi, Congresswoman Nancy02-Apr-99 #316Vaccine and Microbicide Tax Credit Legislation Introduced in Congress
phenotypic testing02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
PHS guidelines03-Sep-99 #326Opportunistic Infections: New Treatment Guidelines Published August 20
PHS guidelines21-May-99 #319Updated HIV Treatment Guidelines Available
PMPA19-Nov-99 #331Update on Tenofovir (PMPA) compassionate Access Study
PMPA01-Oct-99 #328ICAAC: New Drugs in Late Breaker Session
Podesta, John16-Apr-99 #317Clinton/Gore Top Staffs: Pharmaceutical Background
poppers20-Aug-99 #325Poppers: More Evidence of Suppressed Immunity
poppers07-May-99 #318VIAGRA: New Warning with Protease Inhibitors
poppers16-Apr-99 #317Poppers: Large Cancer Increase and Immune Suppression in Animal Tests
prices, pharmaceutical22-Jan-99 #311A Visit to India: Drug Prices, Research, & Global Access
protease inhibitors07-May-99 #318VIAGRA: New Warning with Protease Inhibitors
Public Citizen18-Jun-99 #321Action Alert: Drug-Patent Bill Could Cost Patients $3 Billion+...
public relations18-Jun-99 #321Action Alert: Drug- Patent Bill Could Cost Patients $3 Billion+...
radio16-Jul-99 #323New York Area and Worldwide: Call- In Radio Program on HIV
Rangel, Congressman Charles02-Apr-99 #316Vaccine and Microbicide Tax Credit Legislation Introduced in Congress
receptors15-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
reimbursement02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
REMUNE HIV immunogen21-May-99 #319REMUNE Trial Will Stop; New Trials Planned
resistance testing15-Oct-99 #329FDA Advisory Meetings: Adefovir, Nov. 1; Resistance Testing Nov. 2-3
resistance testing02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
resistance testing08-Jan-99 #310 1999: Treatments, Issues to Watch
resveratrol17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
retinoid toxicity19-Mar-99 #315Lipodystrophy: Glaxo Researchers Suggest Mechanisms, Publish Data
Retroconference 200020-Aug-99 #325Retroviruses Conferences Dates and Deadlines
retroviruses conference (1999)19-Feb-99 #313Retroviruses conference: Finding Information on the Web
Retroviruses conference (1999)12-Feb-99 #312HIV- Specific Immunity: Major Conference Sessions
Retroviruses conference (1999)12-Feb-99 #312Retroviruses Conference, Chicago 1999
Retroviruses conference (2000)20-Aug-99 #325Retroviruses Conferences Dates and Deadlines
ribavirin02-Jul-99 #322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
RIGHT (institute)07-May-99 #318Interrupting HAART; Hydroxyurea; Five+ Drug Therapy -- Report from the RIGHT
Roche Diagnostics05-Mar-99 #314Viral Load 50-Copy Test Approved
salvage therapy conference18-Jun-99 #321Salvage Therapy Workshop: More Web Reports
San Francisco07-May-99 #318Managed Care Problems: San Francisco Hearing Set for May 13
San Francisco19-Feb-99 #313San Francisco: New HMO Problems threaten Access to Care
San Francisco General Hospital17-Dec-99 #333San Francisco General Hospital Funding Crisis: Call for Information
San Francisco General Hospital20-Aug-99 #325San Francisco General Hospital: Studies for Patients Beginning Antiretroviral Treatment
San Francisco General Hospital16-Apr-99 #317San Francisco General Outpatient Pharmacy Problems
Sawyer, Eric16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
Scondras, David18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
Scondras, David04-Jun-99 #320 Treatment Interruption Research: The Trial Most Needed Now
Scondras, David22-Jan-99 #311A Visit to India: Drug Prices, Research, & Global Access
Seattle19-Nov-99 #331Seattle Trade Meeting: What Can Be Done for Treatment Access? Interview
Secure the Future21-May-99 #319Hundred Million Dollar Program for Public-Private AIDS Research and
Shaman Botanicals06-Aug-99 #324Diarrhea: New Treatment Option from Shaman
Sharp, Matt03-Sep-99 #326Treatment Advocacy Program Trains 200: Interview with Matt Sharp
Smith, Kendall15-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
Social Security01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
South Africa05-Nov-99 #330Durban Conference: February Deadlines, New Track, and Community Program
South Africa02-Jul-99 #322Africa, Access, and Patents: Moving Fast
South Africa07-May-99 #318Interrupting HAART; Hydroxyurea; Five+ Drug Therapy -- Report from the RIGHT
South Africa16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
SP-30306-Aug-99 #324Diarrhea: New Treatment Option from Shaman
Spanish03-Dec-99 #332Treatment and Related AIDS Email Lists
specialist HIV care22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
SSA (Social Security Administration01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
strategy trials19-Feb-99 #313Strategy Trials: The Answer?
Strub, Sean02-Jul-99 #322Africa, Access, and Patents: Moving Fast
surveys03-Sep-99 #326HIV & AIDS Treatment Registry Database: Public Registry Now Online
surveys16-Jul-99 #323Web-Based Survey: Symptom Management for Persons Living with HIV
survival22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
T-2001-Oct-99 #328ICAAC: New Drugs in Late Breaker Session
T-2016-Jul-99 #323T-20: 5-Drug Combination Trial for Heavily Treated NNRTI-Naive Patients No
T-2008-Jan-99 #310 1999: Treatments, Issues to Watch
T-cell activation16-Apr-99 #317T-Cell Activation Predictive of Poor Survival in Advanced Disease
Tat toxoid17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
TECP03-Sep-99 #326Treatment Advocacy Program Trains 200: Interview with Matt Sharp
telephone information19-Nov-99 #331Restoring HIV- Specific Immunity: Telephone Conference December 8
tenofovir19-Nov-99 #331Update on Tenofovir (PMPA) compassionate Access Study
tenofovir01-Oct-99 #328ICAAC: New Drugs in Late Breaker Session
testosterone04-Jun-99 #320 Threat to Compounding of Topical Testosterone, Other Pharmaceuticals: FDA Proposes Limit on Interstate Shipment
therapeutic vaccination12-Feb-99 #312Restoring HIV- Specific Immunity
treatment activism05-Nov-99 #330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Grinberg
treatment directory01-Oct-99 #328New AmFAR Treatment Directory Now Available
Treatment Education Certification Program03-Sep-99 #326Treatment Advocacy Program Trains 200: Interview with Matt Sharp
treatment interruption04-Jun-99 #320 Treatment Interruption Research: The Trial Most Needed Now
treatment interruption07-May-99 #318Interrupting HAART; Hydroxyurea; Five+ Drug Therapy -- Report from the RIGHT
treatment-naive20-Aug-99 #325San Francisco General Hospital: Studies for Patients Beginning Antiretroviral Treatment
treatment-naive16-Jul-99 #323T-20: 5-Drug Combination Trial for Heavily Treated NNRTI-Naive Patients No
TRIPS05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
tuberculosis19-Feb-99 #313Tuberculosis Control: Many Cases Found Transmitted Despite Negative Result
UNESCO04-Jun-99 #320 AEGIS Nominated to UNESCO "Memory of the World"
vaccine17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
vaccine07-May-99 #318Gates Foundation Donates $25 Million for AIDS Vaccines
vaccine07-May-99 #318U.S. Vaccine Trial: New Email List
vaccine02-Apr-99 #316Vaccine and Microbicide Tax Credit Legislation Introduced in Congress
Valentine, Fred12-Feb-99 #312Restoring HIV-Specific Immunity
vaporizers -- product information17-Sep-99 #327Vaporizers for Medical Marijuana
Vertex Pharmaceuticals07-May-99 #318Amprenavir, New Protease Inhibitor, Approved
Viagra07-May-99 #318VIAGRA: New Warning with Protease Inhibitors
viral load testing05-Mar-99 #314Viral Load 50-Copy Test Approved
viral resistance testing02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
viral resistance testing08-Jan-99 #310 1999: Treatments, Issues to Watch
vitamin B605-Mar-99 #314Neuropathy: Nutritional Prevention/Treatment Suggested
vomiting21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
Walker, Bruce D.02-Jul-99 #322Immune Reconstitution: New Review on Web
wasting syndrome21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
Women and HIV/AIDS conference15-Oct-99 #329Women and HIV/AIDS Conference: Tape, Web Reports Available
work, returning to19-Feb-99 #313Keep Your Medicare in Force As You Go Back to Work (What to Do and When to
working01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
World Trade Organization19-Nov-99 #331Seattle Trade Meeting: What Can Be Done for Treatment Access? Interview with James Love
World Trade Organization03-Sep-99 #326Seattle Demonstration Preparations for Global Trade Meetings
World Trade Organization02-Jul-99 #322Africa, Access, and Patents: Moving Fast
World Trade Organization05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
WTO19-Nov-99 #331Seattle Trade Meeting: What Can Be Done for Treatment Access? Interview with James Love
WTO03-Sep-99 #326Seattle Demonstration Preparations for Global Trade Meetings
WTO02-Jul-99 #322Africa, Access, and Patents: Moving Fast
WTO05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
XIII International AIDS Conference05-Nov-99 #330Durban Conference: February Deadlines, New Track, and Community Program
Ziagen08-Jan-99 #310ZiagenTM (Abacavir) Approved: Caution Essential



Advertisement


ISSN # 1052-4207

Copyright 1999 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.





  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by AIDS Treatment News.
 

Tools
 

Advertisement